Augment Bone Graft All Financial Data in US $ (mln)
Worldwide
 
Overview
 

Word Search (Top 10 - by date)

Wright Medical Group, Inc. Announces Agreement with FDA Office of Device Evaluation to File PMA Amendment for Augment® Bone Graft In Lieu of Dispute Resolution Panel
Mylan (March 10, 2014)
Wright Medical Group, Inc. Reports 2013 Fourth Quarter and Full-Year Financial Results and Provides 2014 Guidance
Wright Medical Group (February 24, 2014)
Wright Medical Group, Inc. Completes Acquisition of OrthoPro, LLC
Wright Medical Group (February 05, 2014)
Wright Medical Group, Inc. Announces Acquisition of Solana Surgical, LLC and Entry into Definitive Agreement to Acquire OrthoPro, LLC
Solana Surgical (January 30, 2014)
Wright Medical Group, Inc. Completes Acquisition of Biotech International
Wright Medical Group (November 15, 2013)
Wright Medical Group, Inc. Reports 2013 Third Quarter Financial Results
Wright Medical Group (November 04, 2013)
Wright Medical Group, Inc. Announces Definitive Agreement to Acquire Biotech International
Wright Medical Group (October 16, 2013)
Wright Medical Group, Inc. Announces Receipt of FDA Not Approvable Letter for Augment® Bone Graft
Wright Medical Group (August 08, 2013)
Wright Medical Group, Inc. Reports 2013 Second Quarter Financial Results
Wright Medical Group (August 05, 2013)
Wright Medical Group, Inc. and MicroPort Scientific Corporation Enter Into Definitive Agreement Under Which MicroPort Will Acquire Wright’s OrthoRecon Business
Wright Medical Group (June 19, 2013)

Displaying 10 out of a possible 66 unique stories.
Results Sorted By date
Display All Stories


EvaluatePharma® - the premier source for pharma and biotech analysis.

Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status (expiry date/ number), deals (upfront/ milestones), license revenues (royalties/ co-promotion) and much more.

Product Name Information

Product: Augment Bone Graft
Generic Name:   becaplermin; beta-tricalcium phosphate
Therapeutic Subcategory:     Bone calcium regulators

Product Sales Summary 2009/10

Annual Sales WW - Sales Growth per Year (%)
Rank1 Generic Name Therapeutic Subcategory 2010
Augment Bone Graft2 0

Clinical Trial Coverage: No. of Trials involving Product

Trial Count
Augment Bone Graft3 1

Welcome

Evaluate provides market intelligence and analysis for the pharma, biotech and medtech industries.

Explore Evaluate


Partnering

EvaluatePharma® now includes Partnering Opportunities - products available for licensing.

Partnering Opportunities in EvaluatePharma® are sourced from the rights holders - all entries are verified by the team of Analysts at EvaluatePharma - and presented in their commercial context.

Register to submit your Partnering Opportunities or to see your own and other Partnering Opportunities in their commercial context with the unique industry-wide analysis in EvaluatePharma®.

Take a full subscription to see all products available for license, including updated contact details for the out-licensing entity.


Register to access more FREE content:

  • 2011 Product Sales analysis
  • Download analysis into Excel
  • Search 2 yrs of company press releases

Research Codes Synonyms

Product: Augment Bone Graft

Register for Free Analysis

Register to access more free insights and analysis from Evaluate.

Register Now